** Shares of CurveBeam AI CVB.AX rise as much as 6.8% to A$0.094, their biggest intraday pct gain since March 31
** The medical equipment manufacturer says that it expects no material impact from tariffs announced by U.S. President Donald Trump
** Co highlights that it conducts majority of its manufacturing activities within the U.S.
** Shares of co fell 16.2% on Monday, in line with the markets sell-off seen globally amid recession fears
** Shares of CurveBeam down 31.1%, YTD
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.